Skip to Content

Paradigm-Changing
Cell Separation Technology.

Better therapeutic outcomes begin with better-quality starting cells.

Akadeum’s GMP microbubble cell separation technology delivers up to a 40% reduction in overall therapeutic manufacturing costs—improving cell quality and potency, persistence, and efficiency on a clinical scale for autologous, allogeneic, iPSC, and any next-generation cell therapeutics.

Data Generated By:

Akadeum's microbubble technology improves production and engineering efficiency of therapeutic CAR-T cells in a scalable manner.

View Our Products

Outcomes Matter: Microbubbles outperform other cell separation methods:

  • Capacity of 100+ billion cells
  • Use with raw, platelet-washed, or cryopreserved material
  • Negative selection capability
  • Compatible with instrumentation in your lab
  • Simple, easy-to-use workflow
Join the Evaluation Program

Everything cell therapy scientists are looking for in cell separation technology.

Superior Cell Health

Higher Potency

Greater Persistence

80% Time Savings

Smaller Footprint

Regulatory Ready

Seamless Integration. Scalable by Design.
Validated Performance.

What Our Customers Are Saying

Simplify and Unify Your Manufacturing Process

Akadeum's GMP microbubbles for cell isolation provide a closed system approach with existing instrumentation or manually in-bag, reducing costs and GMP suite footprint, and enabling more starts in parallel.
Back to Top